0910-AF14 200410 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Treatment Use of Investigational Drugs Substantive, Nonsignificant Previously Published in The Unified Agenda Proposed Rule Stage Undetermined No 21 CFR 312.42 21 CFR 312.400 21 CFR 312.405 21 CFR 312.410 21 CFR 312.415 21 CFR 312.420 21 CFR 312.425 21 CFR 312.430 21 CFR 312.435 21 USC 321 21 USC 331 21 USC 351 to 353 21 USC 353 21 USC 355 21 USC 371 42 USC 262 No NPRM 03/00/2005 Undetermined Businesses Undetermined No Undetermined NA Not Collected Christine Rogers F. 0910 Food and Drug Administration FDA 301 796-3601 301 847-8440 christine.rogers@fda.hhs.gov Suite 3059 (HFD-7), Center for Drug Evaluation and Research, 10903 New Hampshire Avenue, Bldg. 51, Room 6316, Silver Spring MD 20993-0002